Viatris appoints Frank D'Amelio and Michael Severino to Board; Rajiv Malik and Harry Korman to retire

Viatris Inc

Frank D'Amelio (former Pfizer CFO) and Michael Severino (Tessera CEO) appointed independent directors effective May 5, 2025.
Rajiv Malik and Harry Korman will retire at end of current terms in December after the 2025 Annual Meeting.
D'Amelio appointed to Finance Committee; Severino to Science and Technology Committee.
Both new directors bring pharmaceutical and executive experience; company cites ongoing board refreshment.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Rajiv Malik

Director

VTRS · Viatris Inc

Filed: May 5, 2025, 7:59 PM ET

Rajiv Malik and Harry Korman each notified the Company of his intention to not stand for re-election at the 2025 Annual Meeting and to retire as a member of the Board at the end of his current term

Departed

Harry Korman

Director

VTRS · Viatris Inc

Filed: May 5, 2025, 7:59 PM ET

Rajiv Malik and Harry Korman each notified the Company of his intention to not stand for re-election at the 2025 Annual Meeting and to retire as a member of the Board at the end of his current term

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rajiv Malik departed as Director at Viatris Inc.

Action: retire
Role: Director

Exact text from the filing

Rajiv Malik and Harry Korman each notified the Company of his intention to not stand for re-election at the 2025 Annual Meeting and to retire as a member of the Board at the end of his current term

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Harry Korman departed as Director at Viatris Inc.

Action: retire
Role: Director

Exact text from the filing

Rajiv Malik and Harry Korman each notified the Company of his intention to not stand for re-election at the 2025 Annual Meeting and to retire as a member of the Board at the end of his current term

View on SEC.gov

Viatris Inc filing history →

Source: SEC EDGAR

accession 0001140361-25-017356

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.